Vimentin has been described as an antigen recognized by different stereotyped (IGHV3-30-subset 32 [33], IGHV4-39-subset 8 [49]) and non-stereotyped (IGHV3-30 [33]) CLL BCRs. Here, VIM is linked to B-cell chronic lymphocytic leukemia.